Roche Seeks To Increase Holding In Chugai To 59.9 Percent
This article was originally published in PharmAsia News
Executive Summary
Roche plans to buy nearly 10 percent more of Japan's Chugai Pharmaceutical. Roche's plan is to boost its 50.1 percent stake in Chugai to 59.9 percent through a one-month tender offer to shareholders. The two companies have been tied for several years through an alliance that led to Roche turning Chugai into a subsidiary. The original 2001 agreement gave Roche the option of increasing its holdings to 59.9 percent after six years. (Click here for more - a subscription may be required
You may also be interested in...
Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says
The statement, which is part of a final rule on the 340B administrative dispute resolution process, could facilitate manufacturer efforts to seek repayments from hospitals in such cases.
The Aspirin Test For AI?
US FDA Commissioner Robert Califf tells Congress that regulators don’t have to know how artificial intelligence works in medicine, but must make very sure it actually does work.
Mary Beth Clarke, CDER Exec Programs Office Director And Generic User Fee Shepherd, Will Retire
Clarke helped launch GDUFA I and negotiate GDUFA II, chaired the CDER Executive Committee and oversaw many other programs in the US FDA’s drugs center.